Indications and uses
prevents and treats nausea, vomiting or dizziness associated with motion sickness
prevents and treats nausea, vomiting or dizziness associated with motion sickness
dosage should be taken one hour before travel starts adults and children 12 years and over take 2 or 4 caplets once daily or as directed by a doctor
each caplet contains: calcium 28 mg store at 20 o -25°C (68 o -77°F)
Meclizine HCl 12.5 mg
Antiemetic
prevents and treats nausea, vomiting or dizziness associated with motion sickness
in children under 12 years of age unless directed by a doctor.
Do not take this product, unless directed by a doctor, if you have
Do not take this product if you are taking sedatives or tranquilizers, without first consulting your doctor.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
| adults and children 12 years and over | take 2 or 4 caplets once daily or as directed by a doctor |
croscarmellose sodium, dicalcium phosphate, magnesium stearate, microcrystalline cellulose, silicon dioxide, stearic acid
(866) 562-2756 (Mon-Fri 8 AM to 4 PM EST)
PHARBEST
NDC 73057-386-11
Manufactured in the USA
Motion Sickness Relief
MECLIZINE
Meclizine HCl 12.5 mg
Antiemetic
• Motion Sickness • Nausea • Vomiting
1000 CAPLETS
| Class | Version | Type | Effective |
|---|---|---|---|
| MECLIZINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ac6963c4-31c6-325f-ee58-83a0a06597ad | Product name | 5 | 20221206 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 73057-386-08 | 2022-01-31 | C162847 | 48780-1 | d6a99b39-84d4-a426-e053-dadaa90af4c2 | Drug Facts |
| 73057-386-11 | 2022-01-31 | C162847 | 48780-1 | d6a99b39-84d4-a426-e053-dadaa90af4c2 | Drug Facts |
| 73057-386-08 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-84d4-a426-e053-dadaa90af4c2 | Drug Facts |
| 73057-386-11 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-84d4-a426-e053-dadaa90af4c2 | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73057-386-08 | MECLIZINE | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 3 | |
| 73057-386-11 | MECLIZINE | 1000 in 1 BOTTLE, PLASTIC | TABLET | 1000 | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 73057-386 | 73057-386-11, 73057-386-08 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | L11K75P92J | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| MECLIZINE HYDROCHLORIDE | HDP7W44CIO | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MECLIZINE | MECLIZINE HCL 12.5MG | Ulai Health LLC | d304e205-85fa-494a-9a68-ae6855b139b1 | 2025-01-20 | Warnings | 73057-386-08 73057-386-11 73057-386 73057038611 73057038608 2c27a466-defa-b729-e063-6394a90a61d3 d304e205-85fa-494a-9a68-ae6855b139b1 |
Adverse event summaries are temporarily unavailable. Other product information remains available.